Abbott Laboratories lists 10 executives, led by Robert B. Ford, Executive Chairman & CEO (age 51). Philip P. Boudreau is the company's CFO & Executive VP of Finance (age 52).
In fiscal year 2022 the highest-paid executive was Robert B. Ford, Executive Chairman & CEO, with total pay of $4.43 million. The 5 executives with reported pay received $12.51 million in all.
The average age of the executives with a known age is 52; the youngest is 46 and the oldest 55.
Titles, ages and pay from company filings; pay for fiscal year 2022.

Executive Chairman & CEO
CFO & Executive VP of Finance
Executive VP and Group President of Established Pharmaceuticals & Nutritional Products
Executive Vice President of Diabetes Care
Executive VP & Group President of Medical Devices
Senior VP of Business & Technology Services and Chief Information Officer
Vice President of Investor Relations.
VP and Chief Ethics & Compliance Officer
Executive VP, General Counsel & Secretary
Senior Vice President of Global Marketing & External Affairs
| Executive | Title | Age | Total pay |
|---|---|---|---|
| Robert B. Ford | Executive Chairman & CEO | 51 | $4.43 million |
| Lisa D. Earnhardt | Executive VP & Group President of Medical Devices | 55 | $2.39 million |
| Philip P. Boudreau | CFO & Executive VP of Finance | 52 | $2.10 million |
| Christopher J. Scoggins | Executive Vice President of Diabetes Care | 55 | $2.06 million |
| Daniel Gesua Sive Salvadori | Executive VP and Group President of Established Pharmaceuticals & Nutritional Products | 46 | $1.52 million |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
Robert B. Ford (Executive Chairman & CEO), age 51; total pay in fiscal year 2022 was $4.43 million.
Philip P. Boudreau (CFO & Executive VP of Finance), age 52.
Robert B. Ford, Executive Chairman & CEO, with total pay of $4.43 million in fiscal year 2022.
Robert B. Ford (Executive Chairman & CEO), Philip P. Boudreau (CFO & Executive VP of Finance), Daniel Gesua Sive Salvadori (Executive VP and Group President of Established Pharmaceuticals & Nutritional Products), Christopher J. Scoggins (Executive Vice President of Diabetes Care) and Lisa D. Earnhardt (Executive VP & Group President of Medical Devices), and 5 more.